129 related articles for article (PubMed ID: 31897226)
1. E2F1 promotes cancer cell sensitivity to cisplatin by regulating the cellular DNA damage response through miR-26b in esophageal squamous cell carcinoma.
Zhang K; Zhang B; Bai Y; Dai L
J Cancer; 2020; 11(2):301-310. PubMed ID: 31897226
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma.
Chen Z; Zhao L; Zhao F; Yang G; Wang J
Am J Transl Res; 2016; 8(5):1957-70. PubMed ID: 27347306
[TBL] [Abstract][Full Text] [Related]
3. miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.
Zhang K; Dai L; Zhang B; Xu X; Shi J; Fu L; Chen X; Li J; Bai Y
J Cell Physiol; 2015 Apr; 230(4):903-10. PubMed ID: 25216463
[TBL] [Abstract][Full Text] [Related]
4. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
Cataldo A; Cheung DG; Balsari A; Tagliabue E; Coppola V; Iorio MV; Palmieri D; Croce CM
Oncotarget; 2016 Jan; 7(1):786-97. PubMed ID: 26623722
[TBL] [Abstract][Full Text] [Related]
5. miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.
Li J; Liang Y; Lv H; Meng H; Xiong G; Guan X; Chen X; Bai Y; Wang K
Gene; 2017 Aug; 625():1-9. PubMed ID: 28476684
[TBL] [Abstract][Full Text] [Related]
6. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
[TBL] [Abstract][Full Text] [Related]
7. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
[TBL] [Abstract][Full Text] [Related]
8. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
9. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5.
Sun F; Zhang C; Ma D; Wang K
Oncol Lett; 2019 Oct; 18(4):4203-4209. PubMed ID: 31579422
[TBL] [Abstract][Full Text] [Related]
13. Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.
Pan F; Mao H; Bu F; Tong X; Li J; Zhang S; Liu X; Wang L; Wu L; Chen R; Wei H; Li B; Li C; Yang Y; Steer CJ; Zhao J; Guo Y
Oncotarget; 2017 Jan; 8(4):5735-5752. PubMed ID: 27974696
[TBL] [Abstract][Full Text] [Related]
14. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
15. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
Mao Y; Liu J; Zhang D; Li B
Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
[TBL] [Abstract][Full Text] [Related]
16. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
Chen C; Ma Z; Zhang H; Liu X; Yu Z
Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
[TBL] [Abstract][Full Text] [Related]
18. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
19. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]